雾化吸入3%高渗盐水在中度毛细支气管炎患儿中的应用效果

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (529 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To examine the application effect of atomizing inhalation of 3% Hypertonic Saline (HS) in children with moderate bronchiolitis. Methods A total of 72 children with moderate bronchiolitis who were hospitalized in the Department of Pediatrics of Maternal and Child Health Centre of Wuming District from July 2018 to October 2020 were selected as research objects. They were divided into 3% HS group and noral saline (NS) group according to random number table method, with 36 cases in each group. 3% HS 2 ml was used in 3%HS group and NS 2 ml was used in NS group. The clinical severity scores (CSS) and length of hospital stay in the pre-treatment phase, 24, 48, 72 h after treatment and at discharge of two groups were compared, and the adverse effect were observed. Results There were no significant differences in CSS between two groups at 24, 48, 72 h after treatment and at discharge (P>0.05).The CSS in the pre-treatment phase 24, 48, 72 h after treatment and at discharge were significantly decreased over time in 3% HS group, the differences were statistically significant (P<0.05). The CSS in the pre-treatment phase, 24,48, 72 h after treatment and at discharge were significantly decreased over time in NS group, the differences were statistically significant (P<0.05). There was no significant difference in length of hospital stay between groups (P>0.05). No adverse reaction occured in both groups. Conclusion Compared with NS, 3% HS combined with Budesonide, Salbutamol and Ipratropium Bromide Atomized Inhalation in the treatment of moderate bronchiolitis did not significantly reduce the CSS and shorten the length of hospital stay, requiring further study with HS alone.

Key words： 3% Hypertonic Saline Inhalation Bronchiolitis Clinical efficacy Moderate

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Jinyan
	LIANG Xiuye
	LIANG Jinhong
	ZHU Guanlan
	PAN Changfan

Cite this article:

LI Jinyan,LIANG Xiuye,LIANG Jinhong, et al. Application effect of nebulized inhalation of 3% Hypertonic Saline in children with moderate bronchiolitis[J]. 中国当代医药, 2022, 29(8): 99-102.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I8/99

[1]	范娟，李茂军，吴青，等.毛细支气管炎的临床管理--美国儿科学会临床实践指南简介[J].中华实用儿科临床杂志，2015，30（10）：730-732.
[2]	李延琪，杨拴盈.雾化吸入高渗盐水治疗小儿毛细支气管炎的临床观察[J].中国妇幼健康研究，2016，27（9）：1124-1126.
[3]	刘恩梅，陈慧中.努力提高中国儿科医生规范诊治毛细支气管炎的水平[J].中华儿科杂志，2015，53（3）：161-163.
[4]	刘恩梅，陈慧中，钱渊.毛细支气管炎诊断、治疗与预防专家共识（2014年版）[J].中华儿科杂志，2015，53（3）：168-171.
[5]	胡亚美，江载芳，申昆玲，等.诸福棠实用儿科学[M].8 版.北京：人民卫生出版社，2015：1276-1277.
[6]	陈思思，任洛，罗健，等.影响3%高渗盐水雾化吸入治疗毛细支气管炎患儿疗效的多因素分析[J].临床儿科杂志，2016，34（2）：88-92.
[7]	桂永浩，申昆玲，毛萌，等.小儿内科学高级教程[M].1 版.北京：中华医学电子音像出版社，2017：210-211.
[8]	夏翠翠，娄春燕，周明英.改良早期预警评分在儿童毛细支气管炎护理中的应用[J].中国当代医药，2020，27（1）：232-234.
[9]	王浩，尚云晓.雾化吸入药物对毛细支气管炎患儿发作期治疗的机制研究进展[J].国际儿科学杂志，2013，40（5）：450-453.
[10]	洪建国，陈强，陈志敏，等.儿童常见呼吸道疾病雾化吸入治疗专家共识[J].中国实用儿科杂志，2012，27（4）：265-269.
[11]	彭万胜，陈信，李冬娥，等.雾化吸入高渗盐水治疗婴幼儿毛细支气管炎疗效和安全性的Meta 分析[J].中国循证儿科杂志，2011，6（5）：358-363.
[12]	周华，吉山宝，姜媛渊，等.高渗盐水雾化吸入治疗婴幼儿毛细支气管炎临床随机对照试验Meta 分析[J].中国实用儿科杂志，2015，30（11）：842-847.
[13]	孙平平，曲书强.毛细支气管炎的研究进展[J].临床肺科杂志，2014，19（7）：1312-1314.
[14]	何丽，吴至凤，肖静.3%高渗盐水联合沙丁胺醇雾化吸入治疗毛细支气管炎疗效的Meta 分析[J].中华肺部疾病杂志（电子版），2020，13（5）：669-672.
[15]	喻文，罗红敏.不推荐急诊科雾化吸入高渗盐水治疗婴儿毛细支气管炎：一项单中心随机临床试验[J].中华危重病急救医学，2014，26（12）：889.
[16]	陆娇，顾珺，马卫宁，等.雾化吸入不同浓度高渗盐水治疗中重度毛细支气管炎的疗效和安全性研究[J].中国小儿急救医学，2017，24（6）：425-429.
[17]	李光璞，赵京.雾化吸入高渗盐水治疗毛细支气管炎的效果观察[J].中华儿科杂志，2014，52（8）：607-610.
[18]	侯爱萍，张小华.不同浓度盐水雾化吸入对毛细支气管炎患儿治疗效果的对比[J].中国妇幼健康研究，2016，27（3）：343-345.
[19]	罗征秀，徐秀娟.毛细支气管炎诊治进展[J].中华实用儿科临床杂志，2017，32（4）：253-255.
[20]	申昆玲，邓力，李云珠，等.糖皮质激素雾化吸入疗法在儿科应用的专家共识（2014年修订版）[J].临床儿科杂志，2014，32（6）：504-511.
[21]	吉大章，冯婉莉，冼建妹.吸入糖皮质激素治疗儿童呼吸道合胞病毒相关喘息的机制及疗效[J].中国小儿急救医学，2012，19（4）：425-427.
[22]	王浩，尚云晓.吸入高渗盐水及肾上腺素对治疗急性中重度毛细支气管炎患儿疗效的研究[J].中国小儿急救医学，2015，22（1）：22-26.